Trinity Biotech (TRIB) Operating Expenses (2009 - 2024)

Trinity Biotech (TRIB) has reported Operating Expenses for 16 consecutive years, with -$10.8 million the latest figure, recorded in Q4 2024.

• Quarterly Operating Expenses fell 29.24% year-over-year to -$10.8 million in Q4 2024, while the trailing twelve-month figure through Dec 2025 was -$18.3 million (up 47.32% YoY) and the FY2025 annual result came in at $28.3 million, down 11.41% from the prior year.
• Operating Expenses retreated to -$10.8 million in Q4 2024 per TRIB's latest filing, from -$7.5 million in the prior quarter.
• Over the last five years, Operating Expenses for TRIB reached as high as -$6.2 million in Q2 2020 and fell as low as -$20.0 million in Q2 2023.
• A 5-year average of -$9.2 million and a median of -$8.0 million in 2020 frame the typical range for Operating Expenses.
• Annual changes were most pronounced in 2023 — Operating Expenses plunged 168.47% — and 2024, when it jumped 60.61%.
• Year by year, Operating Expenses stood at -$8.2 million in 2020, then rose by 9.29% to -$7.4 million in 2021, then plunged by 87.52% to -$13.9 million in 2022, then soared by 39.84% to -$8.3 million in 2023, then dropped by 29.24% to -$10.8 million in 2024.
• According to Business Quant data, Operating Expenses over the past three periods registered -$10.8 million, -$7.5 million, and -$7.9 million for Q4 2024, Q3 2024, and Q2 2024 respectively.